发明申请
US20110144001A1 HIGHLY BRIDGED PEPTIDES FROM ACTINOMADURA NAMIBIENSIS
审中-公开
来自ACTINOMADURA NAMIBIENSIS的高度桥联蛋白
- 专利标题： HIGHLY BRIDGED PEPTIDES FROM ACTINOMADURA NAMIBIENSIS
- 专利标题（中）： 来自ACTINOMADURA NAMIBIENSIS的高度桥联蛋白
-
申请号： US12895106申请日： 2010-09-30
-
公开(公告)号： US20110144001A1公开(公告)日： 2011-06-16
- 发明人: Mark BROENSTRUP , Hans GUEHRING , Holger HOFFMANN , Joachim WINK , Roderich SUESSMUTH , Timo SCHMIEDERER
- 申请人： Mark BROENSTRUP , Hans GUEHRING , Holger HOFFMANN , Joachim WINK , Roderich SUESSMUTH , Timo SCHMIEDERER
- 申请人地址： FR PARIS
- 专利权人： SANOFI-AVENTIS
- 当前专利权人： SANOFI-AVENTIS
- 当前专利权人地址： FR PARIS
- 优先权： EP08290324.6 20080402
- 主分类号： A61K38/10
- IPC分类号： A61K38/10 ; C07K7/00 ; A61P31/12 ; A61P31/04 ; C12N15/31 ; A61P29/00
摘要：
The invention refers to so-called Labyrinthopeptin derivatives of the formula (I) wherein {A}, {B}, {C}, R1-R6, m and n are as defined herein, obtainable from microorganism strain Actinomadura namibiensis (DSM 6313), its use for the treatment of bacterial infections, viral infections and/or pain, a pharmaceutical composition comprising it, prepro-Labyrinthopeptin, pro-Labyrinthopeptin, and DNA coding for prepro-Labyrinthopeptin and pro-Labyrinthopeptin.